baber/WOPTO huggingface dataset:
Patent CA-2593726-C (CA)
Title: Apparatus and method for controlling rotational speed and direction of a crop sprayer
Inventor: RINGER CHAD A
IPC: A01M7/00
Filed: 2007-06-27
Granted: 2014-10-21
Abstract: A crop sprayer control assembly includes a hand-operated control device with an up-throttle sensor operably connected to the hand-operated control device. A down--throttle sensor, an up-shift sensor and a down-shift sensor are also operably connected to the hand-operated control device.
Patent CA-2594008-C (CA)
Inventor: ARGAUD THIERRY
IPC: F02C7/16
Filed: 2007-07-16
Granted: 2014-11-04
Abstract: Ventilation system for a downstream impeller cavity in a centrifuge compressor in a turbine engine, this system including the means (70, 84) to divert the flow, securely mounted in the downstream cavity (38) of the impeller (36) to divert the ventilation air withdrawn at the output of the compressor (10) and to circulate it radially from the interior to the exterior along the downstream face (34) of the impeller.
Patent CA-2599018-C (CA)
Title: Procedes et systemes pour utiliser un generateur d'aerosols
Inventor: FINK JAMES B
IPC: A61M16/00
Filed: 2006-03-22
Granted: 2014-05-13
Abstract: L'invention concerne un procédé pour traiter un patient souffrant d'une maladie pulmonaire, le procédé consistant à administrer par intermittence une dose de médicament sous forme d'aérosol à un circuit de ventilateur couplé au système respiratoire du patient. L'invention concerne aussi un procédé pour traiter un patient souffrant d'une maladie de poumons, le procédé consistant à désaccoupler le ventilateur du patient et à administrer au patient un aérosol nébulisé comprenant entre environ 100 ?g et environ 500 mg d'un médicament. De plus, l'invention concerne un médicament sous forme d'aérosol destiné au traitement d'une maladie pulmonaire, le médicament comprenant l'amikacine mélangée avec une solution aqueuse ayant un pH ajusté entre environ 5,5 et environ 6,3. Le pH est ajusté par l'ajout d'acide hydrochlorique et d'hydroxyde de sodium à la solution aqueuse.
Patent CA-2603627-C (CA)
Title: Closing device
Inventor: KELLER ERNST
IPC: E05B15/14
Filed: 2006-04-07
Granted: 2013-09-24
Abstract: The invention relates to a closing device which comprises a stationary part (2) and a part (3) which is displaceably mounted thereon. Tumblers (Z1-Z5) are arranged by means of a key (19) in order to release the displaceable part (3).  Said tumblers (Zl -Z5) are maintained in a locking position by means of the locking element (14, 27, 33). The locking element (14, 27, 33) can be adjusted by means of a drive (13, 23, 30) in order to release the tumblers (Z1-Z5), which can be controlled via an electronic control device (16).
Patent CA-2606395-C (CA)
Inventor: PINDER HOWARD G
IPC: H04N21/4405
Filed: 2006-04-27
Granted: 2012-01-17
Abstract: Processing an MPEG elementary stream contained in multiple PID streams in a conditional access overlay environment. A multi-program transport stream contains numerous video and audio elementary streams. Critical packets in the elementary streams are encrypted with two different encryption schemes creating a stream having multiple PID values. The streams are then sent from the headend to individual set-top boxes. One encryption scheme can be decoded by the incumbent set-top box and the second encryption scheme can be decoded by the overlay set-top box. The overlay set-top box uses a dual filter system to filter and decode the PIDs for each video and audio stream of the desired program.
Patent CA-2610087-C (CA)
Title: Promoteur de l'expression de transgenes specifique a l'epiderme, pouvant etre induite par des pathogenes dans des plantes
Inventor: SCHWEIZER PATRICK
IPC: C12N15/82
Filed: 2006-05-30
Granted: 2015-11-24
Abstract: L'invention concerne des régions de promoteurs contrôlant l'expression de transgènes spécifique à l'épiderme, pouvant être induite par des pathogènes, dans des plantes. L'invention concerne également des molécules d'acides nucléiques de recombinaison contenant ces promoteurs et des plantes et cellules végétales transgéniques transformées au moyen de ces molécules d'acides nucléiques, ainsi que des procédés de fabrication de ces molécules. L'invention concerne également des molécules d'acides nucléiques contenant un promoteur selon l'invention et des séquences d'acides nucléiques ou des transgènes pouvant conférer une résistance aux pathogènes, des plantes et cellules végétales transgéniques transformées au moyen de ces molécules d'acides nucléiques, ainsi que des procédés de fabrication de ces molécules. L'invention concerne par ailleurs l'utilisation de la région de promoteur selon l'invention pour l'étude de voies de transduction de signaux induites par des pathogènes dans des plantes.
Patent CA-2610415-C (CA)
Title: Handheld electronic device including auto completion of punctuation in numerical entry, and associated method
Inventor: SCOTT SHERRYL LEE LORRAINE
IPC: G06F17/27
Filed: 2007-11-09
Granted: 2012-01-17
Abstract: The disclosed and claimed concept describes a handheld electronic device that has the capability to automatically prefer a preferred punctuation arrangement in response to determining whether a first output has a predetermined characteristic.
Patent CA-2610692-C (CA)
Title: Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves
Inventor: OHMOTO KAZUYUKI
IPC: C07D277/56
Filed: 2006-06-02
Granted: 2014-11-25
Abstract: An EP2 agonist which may have an EP3 agonistic effect has an effect of regenerating and/or protecting nerves, and is therefore useful as a therapeutic agent for a disease of the peripheral nervous system, such as a lower or upper motor neuron disease, a nerve root disease, plexopathy, thoracic outlet compression syndrome, peripheral neuropathy, neurofibromatosis and neuromuscular transmission disease. An EP2 agonist which has an EP3 agonistic effect is a safe and effective agent for the regeneration and/or protection of nerves which has little influence on the circulatory system.
Patent CA-2620449-C (CA)
Title: Method and apparatus for producing synergistic biocide
Inventor: SINGLETON FREDDIE L
IPC: A01N33/02
Filed: 2006-08-24
Granted: 2012-03-27
Abstract: An apparatus and methods to produce synergistic mixtures (or combinations) of haloamines to control growth of microorganisms in aqueous systems are disclosed. The apparatus and methods to produce synergistic mixtures entails producing a batch quantity of a haloamine and converting part of the haloamine to a second haloamine species to form the synergistic mixture.
Patent CA-2628777-C (CA)
Inventor: GUILFORD F TIMOTHY
IPC: A61K9/127
Filed: 2005-11-07
Granted: 2016-09-13
Abstract: The invention is a composition administrable orally to provide systemic glutathione (reduced) and a method for providing systemic glutathione by oral administration of glutathione (reduced) in a liposome encapsulation. The administration of a therapeutically effective amount of oral liposomal glutathione (reduced) results in improvement of symptoms in disease states related to glutathione deficiency such as Parkinson's disease and cystic fibrosis. Compounds enhancing the effect of the liposomal glutathione are contemplated such as Selenium, EDTA, carbidopa, and levodopa.
Patent CA-2631098-C (CA)
Title: Systeme et procede de commande d'une admission de diffusion de message
Inventor: WEISER DOUGLAS
IPC: H04W4/90
Filed: 2006-11-20
Granted: 2013-06-25
Abstract: La présente invention concerne un système et un procédé de commande d'admission pour autoriser la soumission d'un message de diffusion à une zone cible de diffusion qui comprend la réception d'un enregistrement de message de diffusion comprenant la zone cible de diffusion pour le message de diffusion et la validation de l'autorité d'un auteur d'un message de diffusion créant l'enregistrement de message de diffusion sous forme de fonction d'un paramètre d'auteur de message de diffusion. Le procédé passe aussi par l'identification d'un réseau de transmission de diffusion envoyant une transmission de message de diffusion aux périphériques recevant le message de diffusion situés dans la zone cible de diffusion et validant le réseau de transmission de diffusion par rapport à un paramètre de réseau de transmission de diffusion. Le procédé comprend également le transfert de l'enregistrement du message de diffusion vers une interface de sortie associée au réseau de transmission de diffusion pour transmission aux périphériques recevant le message de diffusion dans la zone cible de diffusion.
Patent CA-2631811-C (CA)
Inventor: PETERSEN HOLGER
IPC: A61K38/31
Filed: 2006-12-20
Granted: 2017-06-20
Abstract: The present invention relates to sustained release formulations comprising as active ingredient octreotide or a pharmaceutically-acceptable salt thereof and two or more different polylactide-co-glycolide polymers (PLGAs).
Patent CA-2631852-C (CA)
Inventor: KUCABA TRACY
IPC: B41F17/00
Filed: 2006-12-06
Granted: 2012-02-21
Abstract: L'invention concerne un ensemble d'alimentation en liquide destiné à être utilisé avec un système d'impression d'un type dans lequel un liquide est déposé à partir de l'ensemble d'alimentation en liquide dans une région réceptrice d'une plaque et tout excédent de liquide dans la région réceptrice est éliminé par raclement de la plaque par l'ensemble d'alimentation en liquide. A cette fin, l'ensemble d'alimentation en liquide fait appel à un gobelet réutilisable, à un insert de gobelet jetable et à un élément racleur. Une fois l'ensemble monté, le gobelet réutilisable comprend un réservoir de liquide réutilisable, l'insert de gobelet jetable comprend un réservoir de liquide temporaire contenant le liquide à l'intérieur du réservoir de liquide réutilisable et l'élément racleur comprend un conduit facilitant un écoulement du liquide contenu par le réservoir de liquide temporaire à travers le conduit et jusqu'à la plaque.
Patent CA-2643122-C (CA)
Inventor: VINCI LUCA
IPC: A61M1/16
Filed: 2006-03-02
Granted: 2012-08-07
Abstract: L'invention concerne un raccord hydraulique réalisé entièrement en une matière élastomérique connectant des tubes ou autres composants du circuit hydraulique servant dans des machines de traitement extracorporel du sang. Le raccord hydraulique comporte un corps principal (2), qui définit un conduit (3), et un nombre prédéterminé de protubérances (6) façonnées pour permettre un enclenchement stable du raccord sur une extrémité d'un orifice tubulaire (7) de tubulure ou autre composant hydraulique. Le conduit (3) présente une première partie longitudinale (3a) dirigée le long d'un premier axe de développement (9) et une deuxième partie longitudinale (3a) dirigée le long d'un deuxième axe de développement (10) ; les axes (9, 10) ne coïncidant pas.
Patent CA-2643314-C (CA)
Inventor: BRAVO PABLO ENRIQUE
IPC: H01H9/02
Filed: 2007-02-22
Granted: 2016-03-29
Abstract: An emergency power supply for an electrical device that provides power sufficient to operate the emergency flotation system for a predetermined period of time after a malfunction of a primary power source. The emergency power supply includes at least one capacitor and a control circuit that are disposed in a housing that is sealed to prevent ingress of liquids. The emergency power supply remains functional even when it is partially submerged.
Patent CA-2643505-C (CA)
Title: Apparatus and method for deliquifying a well
Inventor: CROTEAU ALBERT
IPC: E21B34/10
Filed: 2008-11-07
Granted: 2016-01-19
Abstract: The invention is directed to an apparatus, system and method for deliquifying a well. A body having gas supply passages is lowered into a well bore on the end of a string of supply tubing. A string of return tubing is lowered through the supply tubing and is inserted into a return passage in the body. A jet nozzle receives gas from the gas supply passages and elevates a fluid:gas mixture to the surface through the return tubing.
Patent CA-2643512-C (CA)
Title: Grouping of users for mimo transmission in a wireless communication system
Inventor: KIM BYOUNG-HOON
IPC: H04L1/00
Filed: 2007-03-19
Granted: 2013-11-19
Abstract: Techniques for supporting MIMO transmission are described. User equipments (UEs) are classified into a first group of UEs to be scheduled individually and a second group of UEs that can be scheduled together. The classification may be based upon the number of transmit and receive antennas, sector loading, data requirements, long-term channel statistics, the number of UEs, etc. Channel quality indicator (CQI) information received from the UEs is interpreted in different manners depending on the groups to which the UEs belong. A single UE may be selected at a time from the first group or multiple UEs may be selected at a time from the second group for MIMO transmission. A MIMO transmission may be sent to a single UE in the first group or multiple UEs in the second group at rates selected based upon the CQI information.
Patent CA-2644906-C (CA)
Inventor: HILBERT DAVID
IPC: A61K39/00
Filed: 2007-03-06
Granted: 2016-05-10
Abstract: The present invention provides chimeric and humanized versions of anti-CD22 mouse monoclonal antibody, HB22.7. The anti-CD22 antibodies of the invention comprise four human or humanized framework regions of the immunoglobulin heavy chain variable region ("VH") and four human or humanized framework regions of the immunoglobulin light chain variable region ("VK"). The invention further comprises heavy and/or light chain FW regions that contain one or more backmutations in which a human FW residue is exchanged for the corresponding residue present in the parental mouse heavy or light chain. Human or humanized VH framework regions of antibodies of the invention may comprise one or more of the following residues: a valine (V) at position 24 of framework region 1, a glycine (G) at position 49 of framework region 2, and an asparagine (N) at position 73 of framework region 3, numbered according to Kabat. The invention further relates to pharmaceutical compositions, immunotherapeutic compositions, and methods using therapeutic antibodies that bind to the human CD22 antigen and that preferably mediate human ADCC, CDC, and/or apoptosis for: the treatment of B cell diseases and disorders in human subjects, such as, but not limited to, B cell malignancies, for the treatment and prevention of autoimmune disease, and for the treatment and prevention of graft- versus-host disease (GVHD), humoral rejection, and post-transplantation lymphoproliferative disorder in human transplant recipients.
Patent CA-2649622-C (CA)
Inventor: YOU HWA-SUN
IPC: H04B7/26
Filed: 2007-05-11
Granted: 2013-03-26
Abstract: An uplink (UL) power control apparatus and method in a broadband wireless communication system are provided. The Mobile Station (MS) includes a power controller for calculating a power compensation value using a last transmit power in a previous closed loop power control when a power control mode is changed to an open loop power control, and determining a transmit power according to the open loop power control using the power compensation value; and a transmitter for adjusting and transmitting the transmit power of a UL signal under control of the power controller.
Patent CA-2651432-C (CA)
Inventor: CORET FRANCIS
IPC: B65H3/06
Filed: 2009-01-27
Granted: 2014-03-25
Abstract: Mail item selection device including at least one file (10) cooperating with a multitude of selection rollers facing one another, crossing a reception tray for a stack of mail items, to select the said mail items one by one and to transport them downstream, this file presenting a pre-determined slope with angle .theta. relative to a horizontal plane defined by the reception tray, with a distance between a part of the lower end of the file and the reception tray, greater at the level of the part of the file the closest to a reference wall (34), than the part furthest from the reference wall.
Patent CA-2653552-C (CA)
Inventor: DANCSI LAJOSNE
IPC: C07J41/00
Filed: 2007-05-18
Granted: 2013-04-23
Abstract: The present invention relates to a new industrial process for the synthesis of solvate- free 17.alpha.-acetoxy-11.beta.-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione [CDB -2914] of formula (I) which is a strong antiprogestogene and antiglucocorticoid agent. The invention also relates to compounds of formula (VII) and (VIII) used as intermediates in the process. The process according to the invention is the following: i) 3-(ethylene-dioxy)-estra-5(10),9(11)-diene-17-one of formula (X) is reacted with potassium acetilyde formed in situ in dry tetrahydrofuran by known method, ii) the obtained 3-(ethylene-dioxy)-17.alpha.-ethynyl-17.beta.-hydroxy-estra-5(10),9(11)-diene of formula (IX) is reacted with phenylsulfenyl chloride in dichloromethane in the presence of triethylamine and acetic acid, iii) the obtained isomeric mixture of 3-(ethylene-dioxy)-21-(phenyl-sulfinyl)-19-norpregna-5(10),9(11),17(20),20-tetraene of formula (VIII) is reacted first with sodium methoxide in methanol, then with trimethyl phosphite, iv) the obtained 3-(ethylene-dioxy)-17.alpha.-hydroxy-20-methoxy-19-norpregna-5(10),9(11),20-triene of formula (VII) is reacted with hydrogen chloride in methanol, then v) the obtained 3-(ethylene-dioxy)-17.alpha.-hydroxy-19-norpregna-5(10),9(11l)-diene-20- one of formula (VI) is reacted with ethylene glycol hi dichloromethane in the presence of trimethyl orthoformate and p-toluenesulfonic acid by known method, vi) the obtained 3,3,20,20-bis(ethylene-dioxy)-17.alpha.-hydroxy-19-norpregna- 5(10),9(11)-diene of formula (V) is reacted with hydrogen peroxide in a mixture of pyridine and dichloromethane in the presence of hexachloroacetone by known method, vii) the obtained 3,3,20,20-bis(ethylene-dioxy)-17.alpha.-hydroxy-5,10-epoxy-19-norpregn-9(11)-ene of formula (IV), containing approximately a 1:1 mixture of 5.alpha.,10.alpha.- and 5.beta.,10.beta.-epoxides, is isolated from the solution and reacted with a Grignard reagent obtained from 4-bromo-N,N-dimethyl-aniline in tetrahydrofuran in the presence of copper(I) chloride catalyst without separation of the isomers by known method, viii) the obtained 3,3,20,20-bis(ethylene-dioxy)-5.alpha.,17.alpha.-dihydroxy-11.beta.-[4-(N,N-dimethylamino)-phenyl]-19-norpregn-9(11)-ene of formula (III) is reacted with potassium hydrogensulfate in water by known method, ix) the obtained 11.beta.-[4-(N,N-dimethylamino)-phenyl]-17.alpha.-hydroxy-19-norpregn-4,9-diene-3,20-dione of formula (II) is acetylated with acetic anhydride in the presence of perchloric acid by known method, finally x) the solvate-free compound of formula (I) is liberated from the obtained solvate containing compound of formula (I) in a 1 : 1 mixture of ethanol and water at 70° C.
Patent CA-2653965-C (CA)
Inventor: JOHNSON DWIGHT N
IPC: E03D3/06
Filed: 2007-05-31
Granted: 2013-03-19
Abstract: A control stop (16) for a flush valve (22) for a urinal or toilet fixture includes a housing (28) defining a flow chamber (38) divided by a valve seat (42) into inlet (44) and outlet (46) sections. A valve structure (54) is biased toward the valve seat (42) by a spring (78) applying a valve closing spring force. The housing (28) is sealed by a diaphragm (70), and the diaphragm covers the movable valve structure (54), isolating it from water flowing through the housing. The diaphragm (70) does not impede valve structure movement, and the closing spring force establishes a threshold water supply pressure for opening the control stop (16) during increasing pressure following a no or low supply pressure condition. A plurality of control stops (16A 16H) may supply a bank of flush valves (22A - 22H) and fixtures, and open in a cascading sequence during increasing pressure as a result of having springs with different closing spring forces.
Patent CA-2658117-C (CA)
Inventor: DAVIDOVITS JOSEPH
IPC: C04B7/26
Filed: 2007-07-26
Granted: 2014-05-13
Abstract: Geopolymeric cements based on aluminosilicate fly ash of class F, which, contrary to the prior art, are harmless to use and harden at ambient temperature, favouring their use in common applications in the construction and civil engineering fields. This harmlessness is achieved thanks to a mixture containing: 10 to 15 parts by weight of a non-corrosive alkali metal silicate solution in which the M2O:SiO2 molar ratio is less than 0.78, preferably less than 0.69, and the SiO2:M2O ratio is greater than 1.28, preferably greater than 1.45, M denoting Na or K; added to this are 10 to 20 parts by weight of water and 5 to 15 parts by weight of blast-furnace slag having a specific surface area of less than 400 m2/kg, preferably less than 380 m2/kg and also 50 to 100 parts by weight of class F aluminosilicate fly ash.
Patent CA-2661557-C (CA)
Inventor: BALADI GEORGE JOSEPH
IPC: B60R22/03
Filed: 2007-09-19
Granted: 2013-11-26
Abstract: A seatbelt retention device (30) comprises a base (31) to be located on the upper seat surface (22) of a vehicle seat (20) and a seatbelt catch (32) mounted on the base (31) and adapted to retain the waist section (13) of a seatbelt (10). The seatbelt retention device (30) receives a passenger (50) on the base (31) in use, such that the catch (32) is accessible between the legs (51) of the passenger (50). A vehicle seat assembly may incorporate the seatbelt catch (32) mounted in the seat (20) and projecting through the upper seat surface (22) so as to be accessible between the legs (51) of a passenger (50) seated on the upper seat surface (22).
Patent CA-2663533-C (CA)
Title: Procede de forage directionnel avec moteur de forage orientable
Inventor: HACI MARC
IPC: E21B7/06
Filed: 2007-09-11
Granted: 2013-07-09
Abstract: La présente invention concerne le forage d'un sondage qui comprend le forage rotatif à une première vitesse de rotation jusqu'à ce qu'une première valeur cible soit pratiquement atteinte, le changement de la première vitesse de rotation en une seconde vitesse de rotation lorsqu'un déclencheur est pratiquement atteint, et puis le forage à la deuxième vitesse de rotation jusqu'à ce qu'une seconde valeur cible soit pratiquement atteinte. De préférence, la seconde vitesse de rotation est pratiquement nulle, de façon à ce que le forage à la seconde vitesse de rotation soit un forage par glissement. Enfin, les étapes de forage rotatif à une première vitesse de rotation, changement de la vitesse de rotation en une seconde vitesse de rotation et forage à la seconde vitesse de rotation sont répétées.
Patent CA-2666152-C (CA)
Title: Organic material production system using biomass material and method
Inventor: GENTA MINORU
IPC: C12P19/00
Filed: 2008-10-02
Granted: 2013-12-17
Abstract: An organic material production system using biomass material includes: a hydrothermal decomposition apparatus (13) that causes the biomass material (11) and hot compressed water (12) to countercurrently contact with each other and undergo hydrothermal decomposition, and that transfers a lignin component and a hemicellulose component into the hot compressed water, so as to separate the lignin component and the hemicellulose component from a biomass solid residue; a cellulose enzymatic saccharification device (17) that treats, with an enzyme, cellulose in the biomass solid residue, so as to enzymatically saccharify the cellulose to a first sugar solution containing hexose; an alcohol fermenter (18) that produces alcohols by fermentation using the obtained first sugar solution; a sulfuric acid decomposition device (33) that decomposes, with sulfuric acid, the hemicellulose component in hot water (30) discharged from the hydrothermal decomposition apparatus, which contains the eluted lignin component and the eluted hemicellulose component, so as to decompose the hemicellulose component to a second sugar solution containing pentose; and a second alcohol fermenter (34) that produces, using the second sugar solution containing pentose, alcohols by fermentation.